Autoimmune Encephalitis

Advertisement

cGxPJobs Banner

Imviva Biotech Advances CTA313 CAR-T Program with FDA IND Approval

BOSTON, June 9, 2026 Imviva Biotech announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational...

By cGxPwire Editor
June 11, 2026

Read More

Advertisement

cGxPJobs

Directory